Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) shares traded down 6.2% during mid-day trading on Thursday. The stock traded as low as $45.62 and last traded at $45.8030. Approximately 79,091 shares changed hands during trading, a decline of 82% from the average daily volume of 432,052 shares. The stock had previously closed at $48.84.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. Truist Financial raised their price target on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a "buy" rating in a report on Monday, September 21st. Wall Street Zen raised Guardian Pharmacy Services from a "hold" rating to a "buy" rating in a research note on Saturday, November 14th. Oppenheimer lifted their price target on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an "outperform" rating in a report on Friday, August 7th. Weiss Ratings raised shares of Guardian Pharmacy Services from a "buy (b-)" rating to a "buy (b)" rating in a research report on Monday, November 9th. Finally, KeyCorp began coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They issued an "overweight" rating and a $52.00 target price for the company. Nine equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $45.57.
View Our Latest Report on Guardian Pharmacy Services
Guardian Pharmacy Services Trading Down 3.9%
The business's 50 day simple moving average is $42.91 and its 200 day simple moving average is $39.06. The company has a market cap of $2.97 billion, a P/E ratio of 40.13, a PEG ratio of 2.63 and a beta of 0.06.
Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.33 earnings per share for the quarter, topping analysts' consensus estimates of $0.31 by $0.02. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 5.13%. The firm had revenue of $371.07 million during the quarter, compared to analyst estimates of $365.76 million. Sell-side analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.
Hedge Funds Weigh In On Guardian Pharmacy Services
Institutional investors and hedge funds have recently made changes to their positions in the business. Zacks Investment Management raised its holdings in Guardian Pharmacy Services by 7.3% during the 3rd quarter. Zacks Investment Management now owns 12,239 shares of the company's stock valued at $499,000 after buying an additional 834 shares during the period. New York State Common Retirement Fund increased its position in Guardian Pharmacy Services by 40.5% during the third quarter. New York State Common Retirement Fund now owns 11,100 shares of the company's stock valued at $453,000 after acquiring an additional 3,200 shares during the last quarter. Aquatic Capital Management LLC purchased a new stake in shares of Guardian Pharmacy Services in the third quarter valued at $235,000. Lighthouse Investment Partners LLC boosted its stake in shares of Guardian Pharmacy Services by 28.9% during the 3rd quarter. Lighthouse Investment Partners LLC now owns 8,572 shares of the company's stock worth $350,000 after purchasing an additional 1,920 shares during the period. Finally, First Trust Advisors LP grew its holdings in Guardian Pharmacy Services by 30.3% during the 3rd quarter. First Trust Advisors LP now owns 601,238 shares of the company's stock valued at $24,518,000 after purchasing an additional 139,931 shares during the last quarter.
Guardian Pharmacy Services Company Profile
(
Get Free Report)
Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents' medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.